跳至主要内容
临床试验/ACTRN12621001164886
ACTRN12621001164886招募中3 期

A Randomised Controlled Feasibility Trial of the Mechanisms of the Fertility Enhancing Effect of Lipiodol in Women Undergoing Hysterectomy for Benign Gynaecological Disease

Professor Neil Johnson0 个研究点目标入组 45 人开始时间: 2021年8月27日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 49 Years(—)
性别
Female

入选标准

  • Women of reproductive age (<50 years) and who have a regular cycle that suggests ovulation, who are due to undergo hysterectomy for benign gynaecologcical conditions

排除标准

  • Exclusion criteria are:
  • - Any fibroid larger than 10cm in maximum dimension; (this change was made after 2 participants were recruited and at the initial screening stages of the MoFEEL trial)
  • - Known Malignancy;
  • - Known carrier of organism(s) associated with sexually transmitted infection (STI);
  • - Women scheduled for purely vaginal hysterectomy.
  • Women will complete our modification of the standardised World Endometriosis Research Foundation Endometriosis Phenome Harmonisation Project (EPHect) patient questionnaire, which is appropriate for any woman with benign gynaecological disease entering a research trial.

研究者

发起方
Professor Neil Johnson

相似试验